期刊文献+

Notch1活化对骨髓瘤细胞株RPMI8226增殖及药物敏感性的影响 被引量:3

Effect of Notch1 activation on the proliferation and drug sensitivity of RPMI8226 myeloma cells
下载PDF
导出
摘要 目的观察Notch1信号通路活化与多发性骨髓瘤(MM)发生、发展及耐药的关系,为MM治疗提供新靶点。方法利用携带Notch1-ICN逆转录病毒载体及Notch1-对照病毒(CON)载体感染RPMI8226细胞(分别为病毒组及病毒对照组),同时设未经感染的细胞为未转染组,采用Western blot法检测Notch1-ICN蛋白表达鉴定细胞;采用CCK-8法检测细胞增殖情况及对硼替佐米敏感性的影响;流式细胞术检测细胞周期。结果病毒组Notch1-ICN表达明显上调,约为病毒对照组和未转染组的2.5倍;培养后48、72、96 h病毒组细胞增殖率均显著高于病毒对照组(P均<0.01);随硼替佐米浓度增高,各组细胞抑制作用均逐渐增加,且同浓度条件下病毒组抑制率显著低于病毒对照组及未转染组(P<0.05或0.01);病毒组S期细胞比例明显高于其余两组(P均<0.01)。结论 Notch1信号通路活化与MM的发生、发展及耐药密切相关,有望成为MM治疗的新靶点。 Objective To investigate the relationship between Notchl activation and the occurrence, development and drug resistance of multiple myeloma(MM), so to provide the basis for molecular targeted therapy. Methods Human RP-MI8226 MM cells were infected with Notchl-ICN and Notchl-CON retrovirus stocks (Notchl-ICN group and Notchl-CON group). RPMI8226 cells without infection were defined as untransfected group. Notchl-ICN protein expression was detec- ted by Western blot analysis. CCK-8 was used to detect the proliferation of MM cells and sensitivity to chemotherapeutic drugs. Cell cycle analysis was detected by flow cytometry. Results The relative expression level of Notchl-ICN protein in Notchl-ICN group increased significantly, and was 2.5 fold higher than that in Notchl-CON group or untransfected group, indicating Notchl signal activation in Notchl-ICN group ; the cell proliferation rates in Notchl-ICN group at 48 h, 72 h and 96 h were all significantly increased as compared with those in Notchl-CON group or untransfected group (P 〈0. 01 ), and the inhibitory rate was decreased in RPMI8226-1CN cells at 48 h treated by the same concentration of Bortezomib ( P 〈 0.05 or 0.01 ) ; S phase cells in Notchl-ICN group were increased as compared with that in Notchl-CON group or untransfected group (P 〈 0. 05). Conclusion Notchl activation was closely correlated with the occurrence, development and drug re-sistance of MM ; Notchl signaling is promising to be used as a new target for MM treatment.
机构地区 泰安市中心医院
出处 《山东医药》 CAS 2012年第27期14-16,共3页 Shandong Medical Journal
基金 山东省自然科学基金资助项目(2009ZRA09006) 山东省医药卫生科技发展计划项目(2011HW077)
关键词 NOTCH通路 多发性骨髓瘤 细胞周期 药物敏感性 Notch signaling multiple myeloma cell cycle chemosensitivity
  • 相关文献

参考文献5

  • 1Piro E, Kropp M, Cantaffa R, et al. Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib[ J ]. Ann Hematol, 2012 May 15. [ Epub ahead of print]. 被引量:1
  • 2Kumar SK, Lee JH, Lahuerta JJ, et al. Risk of progression and sur- vival in multiple myeloma relapsing after therapy with IMiDs and bottezomib: A muhicenter international myeloma working group study[ J ]. Leukemia, 2012,26 (5) : 1153. 被引量:1
  • 3Xu D, Hu J, Xu S, et al. Dill/Notch activation accelerates multi- ple myeloma disease development by promoting CD138 MM-cell pro- liferation[J]. Leukemia, 2011, Nov 18. doi: 10. 1038/1eu. 2011. 332. [Epub ahead of print]. 被引量:1
  • 4Nefedova Y, Sullivan DM, Bolick SC, et al. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy [ J ]. Blood, 2008,111 (4) :2220-2229. 被引量:1
  • 5贾向旭,鲁茁壮,王华,段海峰,张群伟,吴祖泽,王立生.激活Notch信号抑制多发性骨髓瘤细胞凋亡[J].中国实验血液学杂志,2004,12(3):335-339. 被引量:10

二级参考文献12

  • 1Tan-Pertel HT,Walker L,Browning D,et al.Notch signaling enhances survival and alters differentiation of 32D myeloblasts.J Immunol,2000; 165:4428 - 4436 被引量:1
  • 2Aster JC,Xu L,Karnell FG,et al.Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notchl.Mol Cell Biol,2000;20:7505 - 7515 被引量:1
  • 3Dievart A,Beaulieu N,Jolicoeur P.Involvement of Notch1 in the development of mouse mammary tumors.Oncogene,1999; 18: 5973-5981 被引量:1
  • 4Uchiyama H,Barut BA,Mohrbacher AF,et al.Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.Blood,1993; 82: 3712 - 3720 被引量:1
  • 5Gupta D,Treon SP,Shima Y,et al.Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion:therapeutic applications.Leukemia,2001; 15:1950 - 1961 被引量:1
  • 6Hideshima T,Chauhan D,Hayashi T,et al.The biological sequelae of stromal cell-derived factor-1 alpha in multiple myeloma.Mol Cancer Ther,2002; 1: 539 - 544 被引量:1
  • 7Artavanis-Tsakonas S,Rand MD,Lake RJ.Notch signaling: cell fate control and signal integration in development.Science,1999;284(5415) :770 - 776 被引量:1
  • 8Pires-daSilva A,Sommer RJ.The evolution of signalling pathways in animal development.Nat Rev Genet,2003 ;4:39- 49 被引量:1
  • 9Davies FE,Rollinson SJ,Rawstron AC,et al.High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.J Clin Oncol,2000;18:284 被引量:1
  • 10Lauta VM.A review of the eytokine network in multiple myeloma:diagnostic,prognostic,and therapeutic implications.Cancer,2003;97: 2440 - 2452 被引量:1

共引文献9

同被引文献23

  • 1许乐,林宗明,朱煜,王国民.过度活化Notch1信号促进肾癌细胞增殖的机制研究[J].肿瘤防治研究,2014,41(2):114-118. 被引量:5
  • 2杨漾,周晓曦,肖敏,洪振亚,龚泉,姜立军,周剑峰.Discovery of Chrysoeriol,a PI3K-AKT-mTOR Pathway Inhibitor with Potent Antitumor Activity against Human Multiple Myeloma Cells in vitro[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2010,30(6):734-740. 被引量:8
  • 3Rao Q,Zheng GG,Li G,et al.Membrane-bound macrophage colony-stimulating factor mediated auto-juxtacrine downregulates matrix metalloproteinase-9 release on J6-1 leukemic cell[J].Exp Biol Med,2004,229(9):946-953. 被引量:1
  • 4Zheng G,Rao Q,Wu K,et al.Membrane-bound macrophage colony-stimulating factor and its receptor play adhesion molecule-like roles in leukemic cells[J].Leuk Res,2000,24(5):375-383. 被引量:1
  • 5Cerretti DP,Wignall J,Anderson D.Human macrophage-colony stimulating factor:alternative RNA and protein processing from a single gene[J].Mol Immunol,1988,25(8):761-770. 被引量:1
  • 6Sherr CJ,Rettenmier CW,Sacca R,et al.The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor,CSF-1[J].Cell,1985,41(3):665-676. 被引量:1
  • 7Wang L,Zheng GG,Ma CH,et al.A special linker between macrophage and hematopoietic malignant cells:membrane form of macrophage colony-stimulating factor[J].Cancer Res,2008,68(14):5639-5647. 被引量:1
  • 8Aharinejad S,Salama M,Paulus P,et al.Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer[J].Endocr Relat Cancer,2013,20(6):777-783. 被引量:1
  • 9Ryder M,Gild M,Hohl TM,et al.Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression[J].PLo S One,2013,8(1):e54302. 被引量:1
  • 10Xu J,Escamilla J,Mok S,et al.CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer[J].Cancer Res,2013,73(9):2782-2794. 被引量:1

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部